Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRAF | P15056 | 20/20 | 0.43 |
| ▸ | ABL1 | P00519 | 1/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.38 |
| ▸ | RAF1 | P04049 | 1/20 | 0.38 |
| ▸ | LCK | P06239 | 1/20 | 0.38 |
| ▸ | YES1 | P07947 | 1/20 | 0.38 |
| ▸ | RET | P07949 | 1/20 | 0.38 |
| ▸ | EPHA1 | P21709 | 1/20 | 0.38 |
| ▸ | TEK | Q02763 | 1/20 | 0.38 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4061796 | 0.86 | BRAF (0.47) | BRAFABL1EGFRRAF1LCK | |
| SCHEMBL13691828 | 0.85 | BRAF (0.43) | BRAFABL1EGFRRAF1LCK | |
| SCHEMBL4053487 | 0.84 | BRAF (0.61) | BRAFABL1EGFRRAF1LCK | |
| SCHEMBL4053209 | 0.79 | BRAF (0.49) | BRAFABL1MAPK14 | |
| SCHEMBL4056069 | 0.79 | BRAF (0.56) | BRAFABL1MAPK14 | |
| SCHEMBL4058317 | 0.78 | BRAF (0.57) | BRAFABL1MAPK14 | |
| SCHEMBL4050893 | 0.78 | PI4KB (0.41) | BRAFABL1MAPK14 | |
| SCHEMBL4059789 | 0.77 | BRAF (0.51) | BRAFABL1MAPK14 | |
| SCHEMBL4052857 | 0.77 | BRAF (0.47) | BRAF | |
| SCHEMBL4053315 | 0.76 | BRAF (0.54) | BRAFABL1MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009111260-A1 | PHENYLSULFONAMIDE-SUBSTITUTED, PYRAZOLO[1, 5-A]PYRIMIDINES, METHODS FOR PREPARATION AND USES THEREOF | WYETH (US) | 2009-09-11 | — | — | WO | disclosed |